Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2026-06-29 @ 8:09 PM
Study NCT ID:
NCT05495035
Status:
UNKNOWN
Last Update Posted:
2023-03-02
First Post:
2022-08-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HQP1351ACE01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None